Acid- and reduction-sensitive micelles for improving the drug delivery efficacy for pancreatic cancer therapy
Source abstract
Abstract
One of the major challenges in anticancer therapy is the poor penetration of anticancer drugs into tumors, especially in solid tumors, resulting in decreased therapeutic efficacy in vivo. To solve some of these problems, in this study, a dual-responsive polymeric micellar system has been developed. This system exhibits an ultrasensitive response to the change of pH value from the extracellular environment to the intracellular environment, resulting in micellar swelling in cancer cells via the proton sponge effect. Moreover, once the swelled micelles escape from the lysosomes in cancer cells, the disulfide linkages are ruptured by GSH in the cytoplasm, leading to the rapid release of the encapsulated drugs into the cellular nuclei. The antitumor activity in pancreatic tumor-bearing mice reveals that this dual-responsive drug delivery system possesses a long blood circulation time and can significantly promote cell internalization and intracellular drug release, achieving a high anticancer efficacy with fewer side effects for normal tissues.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of stomatology and medicine
Foshan University
Foshan
P.R. China
Department of Gastroenterology
Guangyuan People's Hospital
Guangyuan
General surgery
West China-Guangan hospital
Sichuan University Guangan
Funding
Department of Science and Technology of Sichuan Province
References (29)
Show source-provided references
1. Ferrari · Nat. Rev. Cancer · 2005 · 5 · 16110.1038/nrc1566 ↗
2. Duncan · Nat. Rev. Drug Discovery · 2003 · 2 · 34710.1038/nrd1088 ↗
3. Maeda · Adv. Drug Delivery Rev. · 2013 · 65 · 7110.1016/j.addr.2012.10.002 ↗
4. Peer · Nat. Nanotechnol. · 2007 · 2 · 75110.1038/nnano.2007.387 ↗
5. Yamamoto · J. Controlled Release · 2001 · 77 · 2710.1016/S0168-3659(01)00451-5 ↗
6. Kwon · Adv. Drug Delivery Rev. · 1996 · 21 · 10710.1016/S0169-409X(96)00401-2 ↗
7. Hu · J. Controlled Release · 2015 · 206 · 9110.1016/j.jconrel.2015.03.018 ↗
8. Koo · Biomaterials · 2012 · 33 · 148910.1016/j.biomaterials.2011.11.013 ↗
9. She · Biomaterials · 2013 · 34 · 225210.1016/j.biomaterials.2012.12.017 ↗
10. Rosenholm · ACS Nano · 2009 · 3 · 19710.1021/nn800781r ↗
11. Seetharaman · J. Colloid Interface Sci. · 2017 · 492 · 6110.1016/j.jcis.2016.12.070 ↗
12. Guan · Biomacromolecules · 2017 · 18 · 134210.1021/acs.biomac.7b00080 ↗
13. Chen · Colloids Surf., B · 2016 · 143 · 28510.1016/j.colsurfb.2016.03.053 ↗
14. Shenoi · J. Am. Chem. Soc. · 2012 · 134 · 1494510.1021/ja305080f ↗
15. Bachelder · J. Am. Chem. Soc. · 2008 · 130 · 1049410.1021/ja803947s ↗
16. Guo · J. Am. Chem. Soc. · 2016 · 138 · 612710.1021/jacs.6b02435 ↗
17. Zhang · Adv. Mater. · 2017 · 29 · 170231110.1002/adma.201702311 ↗
18. Li · J. Mater. Chem. B · 2016 · 4 · 431310.1039/C6TB00718J ↗
19. Jiao · Mater. Sci. Eng., C · 2016 · 67 · 2610.1016/j.msec.2016.04.091 ↗
20. Wang · J. Am. Chem. Soc. · 2013 · 135 · 980510.1021/ja402903h ↗
21. Yan · Polym. Chem. · 2012 · 3 · 240310.1039/c2py20240a ↗
22. Pasut · J. Controlled Release · 2015 · 199 · 10610.1016/j.jconrel.2014.12.008 ↗
23. Ni · J. Nanosci. Nanotechnol. · 2012 · 12 · 209410.1166/jnn.2012.5753 ↗
24. Pasparakis · Nat. Commun. · 2014 · 5 · 362310.1038/ncomms4623 ↗
25. Cui · J. Controlled Release · 2006 · 114 · 24210.1016/j.jconrel.2006.05.013 ↗
26. Park · J. Controlled Release · 2004 · 95 · 57910.1016/j.jconrel.2003.12.020 ↗
27. Meng · Biomaterials · 2009 · 30 · 218010.1016/j.biomaterials.2009.01.026 ↗
28. Li · Biomaterials · 2014 · 35 · 385110.1016/j.biomaterials.2014.01.018 ↗
29. Wang · Adv. Mater. · 2012 · 24 · 11510.1002/adma.201104066 ↗